TWD
True Wealth Design Portfolio holdings
AUM
$284M
1-Year Return
11.73%
This Quarter Return
+3.01%
1 Year Return
+11.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$273M
AUM Growth
+$35M
(+15%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
60.29%
Holding
893
New
33
Increased
100
Reduced
200
Closed
110
Top Buys
Top Sells
| 1 |
Dimensional Core Fixed Income ETF
DFCF
|
$3.01M |
| 2 |
Dimensional National Municipal Bond ETF
DFNM
|
$1.94M |
| 3 |
PPG Industries
PPG
|
$1.25M |
| 4 |
Broadcom
AVGO
|
$1.17M |
| 5 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$1.05M |
Sector Composition
| 1 | Technology | 4.02% |
| 2 | Industrials | 3.32% |
| 3 | Consumer Discretionary | 3.13% |
| 4 | Healthcare | 3% |
| 5 | Financials | 2.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Aflac
AFL
$57.2B
| $3.61K | ﹤0.01% |
52
| – | – |
|
252
John Hancock Multifactor Mid Cap ETF
JHMM
$4.35B
| $3.58K | ﹤0.01% |
72
| – | – |
|
253
Verizon
VZ
$187B
| $3.16K | ﹤0.01% |
85
-845
| -91% | -$31.4K |
|
254
Comcast
CMCSA
$125B
| $3.08K | ﹤0.01% |
+74
| New | +$3.08K |
|
255
Otis Worldwide
OTIS
$34.1B
| $2.94K | ﹤0.01% |
33
| – | – |
|
256
Adobe
ADBE
$148B
| $2.93K | ﹤0.01% |
6
-39
| -87% | -$19.1K |
|
257
Sony
SONY
$165B
| $2.88K | ﹤0.01% |
160
| – | – |
|
258
Dow Inc
DOW
$17.4B
| $2.72K | ﹤0.01% |
51
| – | – |
|
259
Booking.com
BKNG
$178B
| $2.7K | ﹤0.01% |
1
| – | – |
|
260
Colgate-Palmolive
CL
$68.8B
| $2.68K | ﹤0.01% |
35
| – | – |
|
261
BP
BP
$87.4B
| $2.65K | ﹤0.01% |
75
| – | – |
|
262
DuPont de Nemours
DD
$32.6B
| $2.64K | ﹤0.01% |
37
| – | – |
|
263
Starbucks
SBUX
$97.1B
| $2.58K | ﹤0.01% |
26
| – | – |
|
264
Accenture
ACN
$159B
| $2.47K | ﹤0.01% |
8
-4
| -33% | -$1.24K |
|
265
Schwab International Equity ETF
SCHF
$50.5B
| $2.35K | ﹤0.01% |
132
| – | – |
|
266
Carnival Corp
CCL
$42.8B
| $2.3K | ﹤0.01% |
122
-1,992
| -94% | -$37.5K |
|
267
Abbott
ABT
$231B
| $2.29K | ﹤0.01% |
21
-281
| -93% | -$30.6K |
|
268
Linde
LIN
$220B
| $2.29K | ﹤0.01% |
6
| – | – |
|
269
Teva Pharmaceuticals
TEVA
$21.7B
| $2.26K | ﹤0.01% |
300
| – | – |
|
270
AstraZeneca
AZN
$253B
| $2.22K | ﹤0.01% |
31
| – | – |
|
271
Netflix
NFLX
$529B
| $2.2K | ﹤0.01% |
5
-1
| -17% | -$441 |
|
272
Rio Tinto
RIO
$104B
| $2.17K | ﹤0.01% |
34
| – | – |
|
273
Bristol-Myers Squibb
BMY
$96B
| $2.11K | ﹤0.01% |
33
-224
| -87% | -$14.3K |
|
274
Thermo Fisher Scientific
TMO
$186B
| $2.09K | ﹤0.01% |
4
-3
| -43% | -$1.57K |
|
275
Union Pacific
UNP
$131B
| $2.05K | ﹤0.01% |
10
-370
| -97% | -$75.7K |
|